Thomson acquires Newport Strategies Inc.Newport Newport, town, England Newport, town (1991 pop. 19,758), Isle of Wight, S England. It is also a port and the commercial center of the island, with agricultural markets and light industries (plastics, soft drinks, and woodworking). In the 17th cent. Strategies Inc., a leading provider of competitive intelligence for the pharmaceutical industry, was recently acquired by The Thomson Corporation (NYSE NYSE See: New York Stock Exchange : TOC; TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : TOC), which will make Newport part of the scientific business within the Thomson Scientific Thomson Scientific is one of the five operating divisions of the Thomson Corporation. The Scientific division provides information-based solutions for the Academic, Business and R&D communities. and Healthcare market group. Terms of the transaction were not disclosed. The van Tulleken Company, with offices in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of and London, represented the shareholders of Newport Strategies in the sale. Newport content complements the extensive intelligence information for global pharmaceutical companies currently offered by Thomson. "Using Newport products in conjunction with our existing industy-leading portfolio of information solutions will allow drug makers to make more effective strategic decisions throughout the product life cycle," said Bob Cullen, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Thomson Scientific and Healthcare. Newport offers comprehensive databases and consulting solutions to help drug manufacturers maximize profits in an era of rapidly increasing generic competition. Cullen said the world's top generic pharmaceutical companies rely on Newport's Horizon Global intelligence system to find business development and licensing opportunities, target products for internal development, and identify strategic suppliers of active pharmaceutical ingredients. Thomson reported 2003 revenues of $7.6 billion. Thomson Scientific, 3501 Market St., Philadelphia, PA 19104, 215-386-0100, fax 215-386-6362, www.thomsonscientific.com |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion